Raloxifene Hydrochloride Tablet, Film Coated
Product Images NDC 76282-256

3 FDA label images from Exelan Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 76282-256). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60mg-30 (Mm1)

60mg-30 (Mm1)
Label for Raloxifene Hydrochloride Tablets USP, 60 mg, film-coated oral tablets, in a 30-tablet package. Manufactured by InvaGen Pharmaceuticals, Inc. and labeled for Exelan Pharmaceuticals, Inc. The label includes storage instructions, an NDC barcode (76282-256-30), and states Rx only status.*
FDA Label Image

Raloxifene Graph

Raloxifene Graph
Two line graphs showing total hip mean percentage change from baseline over 24 months after randomization. The first graph compares Raloxifene and placebo subjects from studies NA and EU, with Raloxifene showing an increase and placebo showing a decrease. The second graph compares placebo, Raloxifene, and conjugated estrogens (CE) in hysterectomized women from Study INT, showing CE with the highest increase, Raloxifene moderate increase, and placebo a decrease.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Raloxifene Hydrochloride showing its molecular components including aromatic rings, hydroxyl groups, a sulfur atom, and a chloride ion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.